Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

Topiramate

Trial Locations (1)

32608

UF Health Science Center, Gainesville

Sponsors
All Listed Sponsors
collaborator

Ortho-McNeil Pharmaceutical

INDUSTRY

lead

University of Florida

OTHER